U.S. Transdermal Drug Delivery System Market Size, Share & Trends Report

U.S. Transdermal Drug Delivery System Market Size, Share & Trends Analysis Report By Technology (Iontophoresis, Mechanical Arrays), By Application (Pain Management, Cardiovascular), By Country, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68038-103-0
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Technology
                       1.1.2. Application
                       1.1.3. Country scope
                       1.1.4. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                           1.3.5.1. Data for primary interviews in the U.S.
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                       1.6.2. Approach 1: Commodity flow approach
                       1.6.3. Volume price analysis (Model 2)
                       1.6.4. Approach 2: Volume price analysis
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Technology Outlook
                       2.2.2. Application Outlook
                       2.2.3. Country Outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Transdermal Drug Delivery System Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Industry Value Chain Analysis
                       3.3.1. Reimbursement framework
                   3.4. Market Dynamics
                       3.4.1. Market driver analysis
                           3.4.1.1. Increasing Prevalence of Chronic Diseases
                           3.4.1.2. Technological Advancements
                           3.4.1.3. High Demand for Pain-Free Drug Delivery
                       3.4.2. Market restraint analysis
                           3.4.2.1. High Cost of Transdermal Technology
                           3.4.2.2. Limited Number of Approved Medications
                   3.5. U.S. Transdermal Drug Delivery System Market Analysis Tools
                       3.5.1. Industry Analysis - Porter’s
                           3.5.1.1. Supplier power
                           3.5.1.2. Buyer power
                           3.5.1.3. Substitution threat
                           3.5.1.4. Threat of new entrant
                           3.5.1.5. Competitive rivalry
                       3.5.2. PESTEL Analysis
                           3.5.2.1. Political landscape
                           3.5.2.2. Technological landscape
                           3.5.2.3. Economic landscape
                       3.5.3. Major Deals & Strategic Alliances Analysis
                       3.5.4. Market Entry Strategies
Chapter 4. U.S. Transdermal Drug Delivery System Device: Technology Estimates & Trend Analysis
                   4.1. Definitions and Scope
                       4.1.1. Electroporation
                       4.1.2. Radio Frequency
                       4.1.3. Iontophoresis
                       4.1.4. Microporation
                       4.1.5. Thermal
                       4.1.6. Mechanical arrays
                       4.1.7. Ultrasound
                       4.1.8. Others
                   4.2. Technology Market Share, 2022 & 2030
                   4.3. Segment Dashboard
                   4.4. U.S. Transdermal Drug Delivery System Market by Technology Outlook
                   4.5. Market Technology & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       4.5.1. Electroporation
                           4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Billion)
                       4.5.2. Radio Frequency
                           4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       4.5.3. Iontophoresis
                           4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       4.5.4. Microporation
                           4.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       4.5.5. Thermal
                           4.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       4.5.6. Mechanical Arrays
                           4.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       4.5.7. Ultrasound
                           4.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       4.5.8. Others
                           4.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
Chapter 5. U.S. Transdermal Drug Delivery System: Application Estimates & Trend Analysis
                   5.1. Definitions and Scope
                       5.1.1. CNS
                       5.1.2. Pain Management
                       5.1.3. Cardiovascular
                       5.1.4. Hormone
                       5.1.5. Immunological
                       5.1.6. Metabolic
                       5.1.7. Gastrointestinal
                       5.1.8. Infection
                       5.1.9. Cancer
                       5.1.10. Others
                   5.2. Application Market Share, 2022 & 2030
                   5.3. Segment Dashboard
                   5.4. U.S. Transdermal Drug Delivery System Market by Application Outlook
                   5.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.5.1. CNS
                           5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.2. Pain Management
                           5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.3. Cardiovascular
                           5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.4. Hormone
                           5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.5. Immunological
                           5.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.6. Metabolic
                           5.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.7. Gastrointestinal
                           5.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.8. Infection
                           5.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.9. Cancer
                           5.5.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                       5.5.10. Others
                           5.5.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                           5.5.10.2. Urological
                               5.5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                           5.5.10.3. Blood Disorders
                               5.5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                           5.5.10.4. Respiratory
                               5.5.10.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
                           5.5.10.5. Musculoskeletal
                               5.5.10.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Billion)
Chapter 6. U.S. Transdermal Drug Delivery System Market: Country Estimates & Trend Analysis
                   6.1. U.S. market share analysis, 2022 & 2030
                   6.2. U.S. Market Dashboard
                   6.3. U.S. Market Snapshot
                   6.4. U.S. Market Share and Leading Players, 2022
                   6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
                   6.6. U.S.
                       6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                       7.2.1. Innovators
                       7.2.2. Market Leaders
                       7.2.3. Emerging Players
                   7.3. Vendor Landscape
                       7.3.1. List of key distributors and channel partners
                       7.3.2. Key customers
                       7.3.3. Key company market share analysis, 2022
                       7.3.4. Novartis AG
                           7.3.4.1. Company overview
                           7.3.4.2. Financial performance
                           7.3.4.3. Product benchmarking
                           7.3.4.4. Strategic initiatives
                       7.3.5. Johnson & Johnson
                           7.3.5.1. Company overview
                           7.3.5.2. Financial performance
                           7.3.5.3. Product benchmarking
                           7.3.5.4. Strategic initiatives
                       7.3.6. Viatris Inc.
                           7.3.6.1. Company overview
                           7.3.6.2. Financial performance
                           7.3.6.3. Product benchmarking
                           7.3.6.4. Strategic initiatives
                       7.3.7. Boehringer Ingelheim GmbH Overview
                           7.3.7.1. Financial performance
                           7.3.7.2. Product benchmarking
                           7.3.7.3. Strategic initiatives
                       7.3.8. Biogel Technology, Inc.
                           7.3.8.1. Company overview
                           7.3.8.2. Financial performance
                           7.3.8.3. Product benchmarking
                           7.3.8.4. Strategic initiatives
                       7.3.9. 3M Company
                           7.3.9.1. Company overview
                           7.3.9.2. Financial performance
                           7.3.9.3. Product benchmarking
                           7.3.9.4. Strategic initiatives
                       7.3.10. Noven Pharmaceuticals, Inc.
                           7.3.10.1. Company overview
                           7.3.10.2. Financial performance
                           7.3.10.3. Product benchmarking
                           7.3.10.4. Strategic initiatives
                       7.3.11. 4P Therapeutics, LLC
                           7.3.11.1. Company overview
                           7.3.11.2. Financial performance
                           7.3.11.3. Product benchmarking
                           7.3.11.4. Strategic initiatives
                       7.3.12. Transdermal Corporation
                           7.3.12.1. Company overview
                           7.3.12.2. Financial performance
                           7.3.12.3. Product benchmarking
                           7.3.12.4. Strategic initiatives
                       7.3.13. Echo Therapeutics, Inc.
                           7.3.13.1. Company overview
                           7.3.13.2. Financial performance
                           7.3.13.3. Product benchmarking
                           7.3.13.4. Strategic initiatives


List of Tables

Table 1 List of Abbreviations
Table 2 U.S. transdermal drug delivery system market, by technology, 2018 - 2030 (USD Billion)
Table 3 U.S. transdermal drug delivery system market, by application, 2018 - 2030 (USD Billion)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in the U.S.
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Transdermal drug delivery system: market outlook
Fig. 10 Transdermal drug delivery system market competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Transdermal drug delivery system market driver impact
Fig. 16 Transdermal drug delivery system market restraint impact
Fig. 17 Transdermal drug delivery system market strategic initiatives analysis
Fig. 18 Transdermal drug delivery system market: Technology movement analysis
Fig. 19 Transdermal drug delivery system market: Technology outlook and key takeaways
Fig. 20 Electroporation estimates and forecast, 2018 - 2030
Fig. 21 Radio Frequency market estimates and forecast, 2018 - 2030
Fig. 22 Iontophoresis market estimates and forecast, 2018 - 2030
Fig. 23 Microporation estimates and forecast, 2018 - 2030
Fig. 24 Thermal market estimates and forecast, 2018 - 2030
Fig. 25 Mechanical arrays market estimates and forecast, 2018 - 2030
Fig. 26 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 27 Others market estimates and forecast, 2018 - 2030
Fig. 28 Transdermal drug delivery system market: application movement analysis
Fig. 29 Transdermal drug delivery system market: application outlook and key takeaways
Fig. 30 CNS estimates and forecast, 2018 - 2030
Fig. 31 Pain Management estimates and forecast, 2018 - 2030
Fig. 32 Cardiovascular estimates and forecast, 2018 - 2030
Fig. 33 Hormone estimates and forecast, 2018 - 2030
Fig. 34 Immunological estimates and forecast, 2018 - 2030
Fig. 35 Metabolic estimates and forecast, 2018 - 2030
Fig. 36 Gastrointestinal estimates and forecast, 2018 - 2030
Fig. 37 Infection estimates and forecast, 2018 - 2030
Fig. 38 Cancer estimates and forecast, 2018 - 2030
Fig. 39 Others estimates and forecast, 2018 - 2030
Fig. 40 Urological estimates and forecast, 2018 - 2030
Fig. 41 Blood disorders estimates and forecast, 2018 - 2030
Fig. 42 Respiratory estimates and forecast, 2018 - 2030
Fig. 43 Musculoskeletal estimates and forecast, 2018 - 2030
Fig. 44 U.S. Transdermal drug delivery system market: Country movement analysis
Fig. 45 U.S. Transdermal drug delivery system market: Country outlook and key takeaways
Fig. 46 U.S. market share and leading players
Fig. 47 U.S.
Fig. 48 U.S. market estimates and forecast, 2018 - 2030
Fig. 49 Participant categorization- Transdermal drug delivery system market
Fig. 50 Market share of key market players- Transdermal drug delivery system market 

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon